Design and synthesis of mechanism-based cysteine protease inhibitors and pro-apoptotic 1,4-benzodiazepines.
Emal, Cory Dene
2003
Abstract
Chagas' disease is an incapacitating illness that afflicts 16--18 million people, killing 21,000 each year in the Americas. Patients infected with <italic>Trypanosoma cruzi</italic> who develop the chronic phase of the disease become progressively sick and ultimately die, typically from cardiac failure. Currently there is no satisfactory treatment for Chagas' disease. Malaria is also one of the most important infectious diseases worldwide, as over one million people die each year from infections caused by <italic>Plasmodium falciparum</italic>. Further complicating the treatment of malaria is the increasing resistance to available drugs. There is a great need to develop new chemotherapy for these diseases, and the targeting of essential cysteine proteases of <italic>T. cruzi</italic> and <italic>P. falciparum</italic> has shown to be a promising approach. This work describes the design, synthesis, and evaluation of small molecule inhibitors of parasitic cysteine proteases. A focused library of peptidomimetic vinyl sulfonyl inhibitors was synthesized and shown to contain potent irreversible inhibitors of cruzain, the major cysteine protease of <italic>T. cruzi</italic>. Structure-activity relationships with cruzain were determined. Many compounds displayed increased activity against <italic>T. cruzi</italic> in whole-cell assays, and several were completely trypanocidal in nature. A general relationship between inhibitor hydrophobicity (as measured by clogP) and trypanocidal activity was also uncovered and shown to be independent of structure. Similar compounds were tested against falcipain-2, the best characterized and most important of the three major cysteine proteases of <italic>P. falciparum</italic>. Several inhibitors of falcipain-2 and <italic>P. falciparum</italic> were shown to have IC<sub>50</sub> values in the low-nanomolar range. Structure-activity relationships with both the enzyme and the parasite were identified. Cytotoxicity is an important mechanism for the management of autoimmune diseases, such as systemic lupus erythematosus (SLE), and is important in virtually all cancer treatments. The novel benzodiazepine <bold>Bz-423</bold> has been identified by Prof. G. D. Glick as a pro-apoptotic agent with great potential in the treatment of such diseases. This work describes the design, synthesis and evaluation of a series of analogs of <bold>Bz-423</bold>. These benzodiazepines were useful in determining structural correlates of pro-apoptotic activity, and are currently being used to facilitate target identification studies.Subjects
Apoptotic Based Benzodiazepines-1,4 Chagas' Disease Cysteine Protease Inhibitors Design Falcipain-2 Mechanism Plasmodium Falciparum Pro Synthesis Trypanosoma Cruzi
Types
Thesis
Metadata
Show full item recordCollections
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.